Clinical Trials Browser

Completed × INDUSTRY × ProMune × Clear all

NCT00031278 2011-05-30

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Phase 1/2 Completed

Carcinoma, Neoplasm Metastasis, Neoplasms

NCT00321815 2010-12-23

Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00043368 2009-03-12

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Phase 2 Completed

BreastDermatologicGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Lymphoma, T-Cell

NCT00043394 2009-03-12

CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00043407 2009-02-12

CPG 7909 in Patients Wih Stage IV Renal Cell Cancer

Phase 1/2 Completed

Carcinoma, Renal Cell

NCT00043420 2009-02-12

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Phase 1/2 Completed

DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous

NCT00070629 2009-02-10

CPG 7909 Injection in Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms